These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 11891944
1. Chromosomal integration of Epstein-Barr virus genomes in nasopharyngeal carcinoma cells. Chang Y, Cheng SD, Tsai CH. Head Neck; 2002 Feb; 24(2):143-50. PubMed ID: 11891944 [Abstract] [Full Text] [Related]
2. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens. Tu C, Zeng Z, Qi P, Li X, Yu Z, Guo C, Xiong F, Xiang B, Zhou M, Gong Z, Liao Q, Yu J, He Y, Zhang W, Li X, Li Y, Li G, Xiong W. J Virol; 2017 Sep 01; 91(17):. PubMed ID: 28637758 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line. Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T. Laryngoscope; 2004 May 01; 114(5):855-9. PubMed ID: 15126743 [Abstract] [Full Text] [Related]
4. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Lin CT, Lin CR, Tan GK, Chen W, Dee AN, Chan WY. Am J Pathol; 1997 May 01; 150(5):1745-56. PubMed ID: 9137098 [Abstract] [Full Text] [Related]
5. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies. Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH. Lab Invest; 1998 Jun 01; 78(6):715-26. PubMed ID: 9645762 [Abstract] [Full Text] [Related]
6. Detection of Epstein-Barr Virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines. Teng ZP, Ooka T, Huang DP, Zeng Y. Virus Genes; 1996 Jun 01; 13(1):53-60. PubMed ID: 8938979 [Abstract] [Full Text] [Related]
7. Rearranged Epstein-Barr virus genomes and clonal origin in nasopharyngeal carcinoma. Shimakage M, Chatani M, Ikegami N, Hirai K. Jpn J Cancer Res; 1989 Jul 01; 80(7):612-6. PubMed ID: 2551868 [Abstract] [Full Text] [Related]
8. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines. Lin CT, Chen W, Hsu MM, Dee AN. Lab Invest; 1997 Jun 01; 76(6):793-8. PubMed ID: 9194855 [Abstract] [Full Text] [Related]
10. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Paramita DK, Fachiroh J, Adham M, Tan IB, Haryana SM, Middeldorp JM. Int J Cancer; 2006 Aug 01; 119(3):608-14. PubMed ID: 16572427 [Abstract] [Full Text] [Related]
11. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma. Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ. Ai Zheng; 2006 Feb 01; 25(2):136-42. PubMed ID: 16480574 [Abstract] [Full Text] [Related]
12. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H. J Virol; 2016 Jul 15; 90(14):6475-88. PubMed ID: 27147748 [Abstract] [Full Text] [Related]
13. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. Niemhom S, Kitazawa S, Murao S, Kunachak S, Maeda S. Cancer Lett; 2000 Nov 28; 160(2):199-208. PubMed ID: 11053650 [Abstract] [Full Text] [Related]
14. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma. Karanikiotis C, Daniilidis M, Karyotis N, Bakogiannis C, Economopoulos T, Murray S, Papamichael D, Samantas E, Nikolaou A, Skoura L, Tselis N, Zamboglou N, Fountzilas G. Strahlenther Onkol; 2008 Jun 28; 184(6):325-31. PubMed ID: 18535809 [Abstract] [Full Text] [Related]
15. Epstein-Barr virus (EBV)-positive pyothorax-associated lymphoma (PAL): chromosomal integration of EBV in a novel CD2-positive PAL B-cell line. Daibata M, Taguchi T, Nemoto Y, Saito T, Machida H, Imai S, Miyoshi I, Taguchi H. Br J Haematol; 2002 Jun 28; 117(3):546-57. PubMed ID: 12028021 [Abstract] [Full Text] [Related]
16. Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma. Lin SY, Tsang NM, Kao SC, Hsieh YL, Chen YP, Tsai CS, Kuo TT, Hao SP, Chen IH, Hong JH. Head Neck; 2001 Mar 28; 23(3):194-200. PubMed ID: 11428449 [Abstract] [Full Text] [Related]
17. Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma. Hsiao JR, Jin YT, Tsai ST. Cancer; 2002 Feb 01; 94(3):723-9. PubMed ID: 11857305 [Abstract] [Full Text] [Related]
19. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China. Ji MF, Huang QH, Yu X, Liu Z, Li X, Zhang LF, Wang P, Xie SH, Rao HL, Fang F, Guo X, Liu Q, Hong MH, Ye W, Zeng YX, Cao SM. Cancer; 2014 May 01; 120(9):1353-60. PubMed ID: 24477877 [Abstract] [Full Text] [Related]
20. [A basic study on the association of Epstein-Barr virus with nasopharyngeal carcinoma--detection and genotypic analysis of Epstein-Barr virus associated with nasopharyngeal carcinoma in Japanese patients]. Tamura S. Nihon Jibiinkoka Gakkai Kaiho; 1992 May 01; 95(5):738-47. PubMed ID: 1320117 [Abstract] [Full Text] [Related] Page: [Next] [New Search]